Executive Management Team

The Allergan management team is composed of seasoned industry professionals who collectively have decades of experience and expertise in the pharmaceutical industry spanning a wide array of disciplines. Through its comprehensive network of industry partners and corporate leadership, Allergan is poised to rapidly introduce novel treatments that will enhance the treatment and management of diseases in carefully selected specialty areas.

Brian Adams

Brian Adams, PhD, MBA, Vice President, Business Development

Dr. Adams has a career of over 15 years in the life sciences in both academia and industry. Prior to joining Allergan, he served as Head of Business Development at Cornerstone Therapeutics and Senior Director of Business Development at Shionogi Pharma (formerly Sciele Pharma). Brian originally started with Shionogi as the Intellectual Property Manager and was responsible for handling the company’s patents and trademarks. Before working for Shionogi, he served as a patent agent and scientific advisor at Pabst Patent Group LLP and Holland & Knight, LLP in the areas of biotechnology and chemistry. He has been very active in the Southeast life sciences community and is a member of the SE BIO Board of Directors. Brian has earned a B.S. in Biology from Wake Forest University, a PhD in Molecular and Systems Pharmacology from Emory University, and an MBA from the University of Georgia.

Steven Caras

Steven Caras, MD, PhD, Vice President, Clinical Development

Dr. Steven Caras is a gastroenterologist and biomedical engineer. He has a Bachelors degree in Chemical Engineering from Arizona State University and Masters and Ph.D. degrees in Bioengineering from the University of Utah in Salt Lake City. Steve obtained his medical degree from the University of Miami. He did his residency training in internal medicine at Washington University in St. Louis and his gastroenterology fellowship at University of Virginia in Charlottesville. After his gastroenterology fellowship, Steve worked as a medical reviewer in the Cardio-Renal Division of FDA, where he was mainly involved in antihypertensive and antiarrhythmic drugs.

Dr. Caras has over 16 years of experience in all aspects of Phase I-Phase IV clinical development and medical affairs and has worked for Solvay Pharmaceuticals and for PAREXEL, a large CRO.

Steve currently volunteers for a local chamber of commerce which evaluates pharmaceutical and medical device companies and provides these companies with essential development, regulatory, and business feedback. Steve is also an Adjunct Professor at the University of Georgia's College of Pharmacy's Regulatory Affairs and Clinical Trials Graduate Program.

Mary Lou Freathy

Mary Lou Freathy, JD, Vice President, Regulatory Affairs, Quality, & Manufacturing

Mary Lou has more than 25 years of pharmaceutical experience in quality, regulatory affairs, and manufacturing compliance including over 10 years supporting the growth of life science companies. Mary Lou was previously Senior Vice President of Quality, Regulatory Affairs, and Chief Compliance Officer of G&W Laboratories. Prior to that, she held several executive managerial positions at Paddock Laboratories, Pliva, Inc., and Dey Laboratories where she started her pharmaceutical career. Mary Lou belongs to several professional societies including RAPS, PDA, ISPE, and ASQ. She holds a J.D. from the Empire School of Law, and a B.A. in Chemistry from the State University of New York. She is also a Certified Compliance Professional.

Jason McCarthy

Jason McCarthy, Chief Financial Officer

Jason brings to Allergan over 15 years of progressive accounting, auditing and finance experience from a mixture of public and private companies. Jason most recently managed the accounting function and was responsible for all SEC filings at Lodgian, Inc., an owner and operator of franchised hotels. Prior to Lodgian, Inc., Jason successfully founded his own company specializing in Sarbanes-Oxley implementations and internal control consulting for some of the top public companies in Atlanta. In addition, Jason also worked for PricewaterhouseCoopers in their audit function specializing in real estate and manufacturing. Jason is a Certified Public Accountant in the state of Georgia and a graduate of Ohio University with dual bachelor’s degrees in Accounting and Management Information Systems.

Thom Rowland

Thom Rowland, Vice President, Commercial Operations

Thom Rowland is an industry veteran who started his career as a sales representative for UCB Pharmaceuticals. Thom later held various marketing positions with UCB prior to taking the position of head of marketing for Scandipharm. He played a lead role in turning the Scandipharm business around prior to its sale to Axcan Pharmaceuticals. Thom then served as a Vice President of Sales and Marketing for several business units at Solvay Pharmaceuticals where he was again instrumental in turning around an underperforming area. Thom was one of the founders of Ventrus Biosciences which completed a successful IPO in 2010.

Ed Schutter

Ed Schutter, President & CEO

Ed Schutter has over thirty years of pharmaceutical industry experience and served as President of Sciele (Shionogi) Pharmaceuticals prior to joining Allergan. Prior to his Sciele experience, Ed served as VP of Global Business development at Solvay Pharmaceuticals based in Basel, Switzerland. He also held several senior management roles in commercial operations at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, Ga. Ed has a degree in Pharmaceutical Sciences from Mercer University and an MBA from Kennesaw State University. He serves on the board of Knight Therapeutics (GUD.TO), Vensun Pharmaceuticals, Establishment Labs, Mercer University and GA BIO.

Leslie Zacks

Leslie Zacks, Vice President, General Counsel, and Chief Compliance Officer

Mr. Zacks has been an attorney in Atlanta, Georgia since 1994. He was the EVP, General Counsel and Chief Compliance Officer at Shionogi Pharma, Inc. from 2004-2010. From 2002 to 2004, Mr. Zacks worked at Hunton & Williams LLP where he was a partner in the Intellectual Property Litigation department. Mr. Zacks is a registered patent attorney who has held associate positions at Powell, Goldstein, Frazer & Murphy LLP (now Bryan Cave LLP) and at Carlock, Copeland and Stair, LLP. Mr. Zacks holds a J.D. and a B.A. in English from the University of Florida.